Search Results - Kalamarides, Michel
- Showing 1 - 20 results of 37
- Go to Next Page
-
1
TERT, the target? by Sahm, Felix, Kalamarides, Michel
Published 2018Text -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Increased growth rate of vestibular schwannoma after resection of contralateral tumor in neurofibromatosis type 2 by Peyre, Matthieu, Goutagny, Stephane, Imbeaud, Sandrine, Bozorg-Grayeli, Alexis, Felce, Michele, Sterkers, Olivier, Kalamarides, Michel
Published 2011Text -
11
Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features by Goutagny, Stéphane, Bah, Alpha Boubacar, Henin, Dominique, Parfait, Béatrice, Grayeli, Alexis Bozorg, Sterkers, Olivier, Kalamarides, Michel
Published 2012Text -
12
Broad-Range 16S rRNA PCR with Cerebrospinal Fluid May Be Unreliable for Management of Postoperative Aseptic Meningitis by Zarrouk, Virginie, Leflon-Guibout, Véronique, Robineaux, Sébastien, Kalamarides, Michel, Nicolas-Chanoine, Marie-Hélène, Sterkers, Olivier, Fantin, Bruno
Published 2010Text -
13
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse by Kalamarides, Michel, Niwa-Kawakita, Michiko, Leblois, Hélène, Abramowski, Vincent, Perricaudet, Michel, Janin, Anne, Thomas, Gilles, Gutmann, David H., Giovannini, Marco
Published 2002Text -
14
Natural History of Meningioma Development in Mice Reveals: A Synergy of Nf2 and p16 (Ink4a) Mutations by Kalamarides, Michel, Stemmer‐Rachamimov, Anat O., Takahashi, Masaya, Han, Zhi‐Yan, Chareyre, Fabrice, Niwa‐Kawakita, Michiko, Black, Peter M., Carroll, Rona S., Giovannini, Marco
Published 2007Text -
15
Alternative Splicing of CHEK2 and Codeletion with NF2 Promote Chromosomal Instability in Meningioma by Yang, Hong Wei, Kim, Tae-Min, Song, Sydney S, Shrinath, Nihal, Park, Richard, Kalamarides, Michel, Park, Peter J, Black, Peter M, Carroll, Rona S, Johnson, Mark D
Published 2012Text -
16
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma by Giovannini, Marco, Bonne, Nicolas-Xavier, Vitte, Jeremie, Chareyre, Fabrice, Tanaka, Karo, Adams, Rocky, Fisher, Laurel M., Valeyrie-Allanore, Laurence, Wolkenstein, Pierre, Goutagny, Stephane, Kalamarides, Michel
Published 2014Text -
17
De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors by Peyre, Matthieu, Gauchotte, Guillaume, Giry, Marine, Froehlich, Sébastien, Pallud, Johan, Graillon, Thomas, Bielle, Franck, Cazals-Hatem, Dominique, Varlet, Pascale, Figarella-Branger, Dominique, Loiseau, Hugues, Kalamarides, Michel
Published 2018Text -
18
Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomas by Boin, Alizée, Couvelard, Anne, Couderc, Christophe, Brito, Isabel, Filipescu, Dan, Kalamarides, Michel, Bedossa, Pierre, De Koning, Leanne, Danelsky, Carine, Dubois, Thierry, Hupé, Philippe, Louvard,, Daniel, Lallemand, Dominique
Published 2014Text -
19
Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis by Louvrier, Camille, Pasmant, Eric, Briand-Suleau, Audrey, Cohen, Joëlle, Nitschké, Patrick, Nectoux, Juliette, Orhant, Lucie, Zordan, Cécile, Goizet, Cyril, Goutagny, Stéphane, Lallemand, Dominique, Vidaud, Michel, Vidaud, Dominique, Kalamarides, Michel, Parfait, Béatrice
Published 2018Text -
20
Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study by Graillon, Thomas, Ferrer, Loic, Siffre, Jason, Sanson, Marc, Peyre, Matthieu, Peyrière, Hadrien, Mougel, Grégory, Autran, Didier, Tabouret, Emeline, Figarella-Branger, Dominique, Barlier, Anne, Kalamarides, Michel, Dufour, Henry, Colin, Thierry, Chinot, Olivier
Published 2021Text